Why Ovarian Cancer Diagnosis is Often Delayed
Ovarian cancer diagnosis is delayed primarily because early-stage disease produces few or no symptoms, and when symptoms do occur, they are nonspecific and easily mistaken for common benign conditions—combined with the lack of effective screening tests and the deep anatomical location of the ovaries making physical examination unreliable. 1
Anatomical and Biological Factors
The fundamental challenge stems from the location of the ovaries and the biology of epithelial cancers, which make early detection inherently difficult 2. The ovaries are positioned deep within the pelvis, rendering them inaccessible to routine physical examination. Pelvic examination has poor sensitivity and specificity for detecting asymptomatic ovarian cancer and cannot be relied upon as a screening method 3, 4.
Symptom-Related Delays
Paucity of Early Symptoms
Patients with ovarian cancer confined to the ovary may have few or no symptoms, making clinical diagnosis of early ovarian cancer more difficult 1. This is a critical distinction—symptoms are most commonly seen only with advanced disease 1.
Nonspecific Symptom Presentation
When symptoms do occur, they include:
- Bloating
- Pelvic or abdominal pain
- Difficulty eating or feeling full quickly
- Urinary symptoms (urgency or frequency)
- Abdominal distension
- Constipation or diarrhea
- Fatigue 2, 5
These symptoms are vague and commonly occur in benign conditions 6, leading physicians to initially diagnose patients with irritable bowel syndrome, gastritis, depression, stress, or other non-malignant conditions 7. In a large survey, 95% of women reported symptoms before diagnosis, yet significant delays occurred because these symptoms were attributed to other causes 7.
Patient-Level Delays
Research demonstrates multiple patient factors contributing to delay:
- Symptom interpretation: Women often fail to recognize these nonspecific symptoms as potentially serious, influenced by their personal experiences, cultural background, and social context 8
- Ignoring symptoms: Women who ignored their symptoms were significantly more likely to be diagnosed with advanced disease 7
- Hospital-related anxiety: Particularly post-COVID-19, fear of healthcare settings has led to months-long delays in seeking care 9
Healthcare System Delays
Treatment delays attributable to doctors or the healthcare system are common and include 6:
- Non-investigation of symptoms when initially presented
- Treatment for non-cancer causes without adequate follow-up
- Lack of follow-up when symptoms persist despite treatment
- Referral delays to appropriate specialists
- System delays in scheduling diagnostic procedures
Specific Healthcare Factors Associated with Delayed Diagnosis
From a large US population study, the following factors significantly influenced time to diagnosis 10:
- Omission of pelvic examination at first visit
- Type of first symptom presented
- Number of symptoms (paradoxically, more symptoms associated with longer delays)
- First physician specialty seen
- Race/ethnicity (significant differences, P < .001)
- Geographic region and urban-rural location
- Not initially receiving ultrasound, CT, or CA-125 testing 7
Diagnostic Test Limitations
CA-125 Limitations
CA-125 is elevated in only about 50% of patients with FIGO stage I disease, though it rises to 85% in advanced disease 1. This marker lacks both sensitivity and specificity:
- False positives occur with endometriosis, pelvic inflammatory disease, menstruation, uterine fibroids, and benign cysts 11
- Also elevated in non-gynecological malignancies (breast, lung, colon, pancreatic cancer) 1
Screening Test Failures
Randomized data do not support routine screening for ovarian cancer in the general population 2, 5. Major trials have shown:
- US screening trial with transvaginal ultrasound and CA-125 found that 72% of cancers detected through screening were still late-stage 2
- No professional society currently recommends routine screening 2, 5
- Transvaginal ultrasound alone has shown poor performance as an independent test 3, 4
The Wait Time Paradox
A critical confounding factor in understanding diagnostic delays is the wait time paradox: patients with severe, rapidly progressive disease are diagnosed more quickly but have poorer outcomes, while those with slower-growing tumors may have longer diagnostic intervals but better survival 12. This creates a U-shaped relationship where both very short (median 10 days) and very long (360 days) diagnostic intervals are associated with higher mortality compared to intermediate intervals (80 days) 12.
Common Pitfalls to Avoid
- Dismissing vague abdominal symptoms in women, especially when new and occurring >12 days per month 2
- Failing to perform pelvic examination at initial presentation with relevant symptoms
- Not ordering imaging (transvaginal ultrasound) when symptoms persist despite treatment for presumed benign conditions
- Lack of follow-up when initial treatment for non-cancer diagnoses fails to resolve symptoms 6
- Assuming younger age means lower risk—younger patients experienced longer diagnostic delays in some studies 7
Clinical Implications
When evaluating women with the constellation of bloating, pelvic/abdominal pain, difficulty eating, feeling full quickly, and urinary symptoms—especially if new and frequent—physicians must be cognizant that ovarian pathology may be the cause 2. However, the evidence suggests that even symptom-based screening is not sufficiently sensitive or specific, particularly for early-stage disease 2.
The median time from first symptom-related healthcare encounter to diagnosis in one large US study was only 1.1 months, yet 26% of women required >6 months and 11% required >1 year for diagnosis 10. This highlights that while some delays are unavoidable given disease biology, substantial system-level improvements remain possible through better physician education about ovarian cancer symptomatology 6 and maintaining high clinical suspicion for persistent, unexplained symptoms.